In vitro suppression of the crown gall (Agrobacterium tumefaciens) by compost extracts bacteria

Nine kinds of compost extracts were tested primarily for their efficiency, in vitro, against the causal agent of crown gall Agrobacterium tumefaciens (strain C58). The most efficient extracts were then selected and bacteria contained in these extracts were isolated. Twenty-seven isolates bacteria we...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of innovation and applied studies Vol. 7; no. 2; p. 617
Main Authors Kerkeni, Amel, Mze, Ahmed Marichali, Ouerghemmi, Saloua, Dallai, Sana, Benzarti, Saoussen, Khedher, Mohamed Ben
Format Journal Article
LanguageEnglish
Published Rabat International Journal of Innovation and Applied Studies 01.08.2014
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Nine kinds of compost extracts were tested primarily for their efficiency, in vitro, against the causal agent of crown gall Agrobacterium tumefaciens (strain C58). The most efficient extracts were then selected and bacteria contained in these extracts were isolated. Twenty-seven isolates bacteria were obtained and investigated in vitro with the objective of selecting efficient antagonists against crown gall disease. The bacterial activity is compared to the reference antagonist Agrobacterium rhizogenes K84 by the double layer method. In vitro, analyzing the antagonistic activity revealed that, after incubation at 27 degree C with the pathogen, antagonists tested exhibited considerable inhibitory activity in vitro and reduced the development of the strain C58 of Agrobacterium tumefaciens with variable degrees. In fact, statistical analyses revealed four groups of antagonistic isolates. The highest level of inhibition zone diameter was observed with C5B2 against 19.37 mm in the control. Reduction of pathogen growth reached 38% compared to control. Compost extracts isolates tested in this study may be considered as potential sources of novel bioactive metabolites as well as promising candidates to develop new biocontrol agents for crown gall disease management.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2028-9324
2028-9324